Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients.
News
James Chelnis explores innovative energy-based technologies in aesthetic facial surgery, emphasizing safety, personalized treatments, and future advancements in patient care.
Karolinne M. Rocha, MD, PhD, shares advancements in vision correction and patient satisfaction at the AAO 2025 meeting.
The EXTEND trial provided 5-year follow-up for 10 patients with advanced retinitis pigmentosa, who had previously received MCO-010 during a phase 1/2a trial
Data suggests that EYP-1901 can reduce the number of injections and treatment burden for patients
Adverum Biotechnologies is known for its therapeutic candidate Ixo-vec, in development for the treatment of wet age-related macular degeneration (AMD)
Both business moves further align Topcon with a long-term strategy for promoting data-driven predictive healthcare
The professor from Wills Eye Hospital in Philadelphia, Pennsylvania, explained why it's time to retire the term "sterile" when addressing culture-negative endophthalmitis
SPVN20 is a gene-agnostic, intravitreal AAV-based gene therapy that targets dormant cones to restore vision, according to SparingVision
A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases
The satellite of the US-based University of Miami Health System will offer a “full spectrum of ophthalmic services” in the United Arab Emirates
A recently-updated textbook details major developments in therapeutic and cosmetic keratopigmentation, including superficial and intrastromal techniques
Reporting from the European Society of Retina Specialists annual congress
Providers are rethinking their spaces and systems to streamline care, reduce waste, and improve patient, staff and physician satisfaction
While the FDA requests additional evidence of efficacy for the low-dose atropine eye drop in the US, the formulation has already gained European Commission approval as Ryjunea for slowing paediatric myopia progression.
Joel Schuman, MD, explore the latest advancements in glaucoma laser treatments, including innovative techniques like DSLT and the benefits of selective laser trabeculoplasty
Sahar Bedrood, MD, discusses her experience with the LEOS endoscopic laser system's enhanced precision and efficiency, promising improved patient outcomes in glaucoma surgery.
The novel therapeutic for keratoconus does not require corneal epithelium removal and is slated to launch commercially in early 2026.
A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.
A study shows enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.
At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses
The investigators noted that this report is the first about subretinal drusenoid deposits in Black and Hispanic patients with age-related macular degeneration
The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD
The full range of vision lens debuted at the 2025 ESCRS meeting in Copenhagen
Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported
The agenda includes subspecialty days, evening events and partner programmes from practice management organisations
Research finding challenge the widely-held notion that cosmetic contact lenses are the safest technique for changing eye colour
A pair of studies, conducted in Taiwan and China, indicate that red light therapy could serve as an effective and safe alternative to atropine
Advertisement
Advertisement
